All Reports Events Blogs Videos
Showing 432 results
  • PEAK Matrix®
    Nov. 30, 2017

    The Healthcare and Life Sciences (HLS) landscape has been subject to significant turbulence on account of a gamut of factors including escalating costs, widespread regulatory amendments, changing business models, and evolution of the patient-centric paradigm (with…
  • Viewpoint
    Oct. 27, 2017

    Amidst falling profitability, declining margins, and persistent regulatory uncertainty, healthcare payers are aggressively looking for opportunities to sustain their business. With most of the large payers strategically prioritizing growth in the Medicare Advantage (MA) market, it…
  • PEAK Matrix®
    Oct. 27, 2017

    The Healthcare and Life Sciences (HLS) landscape has been subject to significant turbulence on account of a gamut of factors including escalating costs, widespread regulatory amendments, changing business models, and evolution of the patient-centric paradigm (with…
  • Blog
    Oct. 09, 2017

    The adage, “Disruption does not discriminate,” rang true again with Office Depot’s acquisition of CompuCom last week.The beleaguered office supplies retailer bought the IT infrastructure firm for US$ 1 billion, illustrating yet again the disruptive impact…
  • State of the Market
    Oct. 06, 2017

    Amidst consistent regulatory uncertainty, falling profit margins, and decreasing in-patient volumes, the demand in the healthcare provider IT market is rebounding with primary focus on value-based care initiatives. More than 50% of provider IT spending by…
  • PEAK Matrix®
    Sep. 29, 2017

    The life sciences industry is undergoing a fundamental change in their business model. Shift from blockbuster drug model to precision medicine and specialty drugs has disrupted the life sciences ecosystem. Traditionally, drug discovery cycles took three…
  • Thematic Report
    Sep. 20, 2017

    Healthcare IT security has become a key strategic priority for C-level executives across payer and provider enterprises, given the recent high-level security breaches in the industry. CISOs realize that these breaches have long-ranging impact, and are…
  • Viewpoint
    Aug. 22, 2017

    When Vishal Sikka announced his decision to step down from the post of CEO and MD of Infosys on August 18, 2017, it marked the latest link (though likely not the last one) in the chain…
  • Thematic Report
    Aug. 18, 2017

    The healthcare market in the Middle East is gaining significant traction on account of various factors including government initiatives to encourage medical tourism, evolving health insurance policies, and growing propensity among the local population to consume…
  • Blog
    Aug. 02, 2017

    Outcome-based contracts in the life sciences industry are essentially a risk sharing agreement between a drug manufacturer and its consumers, which include healthcare payers, healthcare providers, and physician groups. The agreement guarantees that if defined care…
  • PEAK Matrix®
    July 28, 2017

    The life sciences clinical and R&D market has been subject to significant turbulence because of several factors including falling R&D productivity, long cycle times, widespread regulatory amendments, and evolution of the patient-centric paradigm (with mobile computing,…
  • Viewpoint
    June 20, 2017

    Government and public health authorities are taking several initiatives to boost the health IT system, which in turn is expected to enable high quality and personalized care. The main goal is to empower and educate consumers…
  • Webinar Deck
    June 02, 2017

    On June 1, Everest Group hosted a webinar called, Trump Cards: Driving Healthcare Innovation During Uncertainty. The Obamacare vs. Trumpcare debate has thrown up more questions than answers. As a result, payers, providers, and life sciences…
  • PEAK Matrix®
    May 31, 2017

    The Healthcare and Life Sciences (HLS) landscape has been subject to significant turbulence on account of a gamut of factors including escalating costs, widespread regulatory amendments, changing business models, and evolution of the patient-centric paradigm (with…
  • Thematic Report
    May 05, 2017

    The drug discovery / product development phase has traditionally been the bottleneck that impedes innovation initiatives within life sciences companies. Patient stratification, outcome uncertainty, unintegrated data platforms, and compliance management are some of the pressing issues…
  • Thematic Report
    May 05, 2017

    Clinical trials execution faces the dual challenges of cost optimization and non-availability of trial targets. Startups leverage NLP, analytics, social media, and IoT technologies to deliver a patient-centric clinical trials approach and also solve for real…
  • Thematic Report
    May 05, 2017

    The life sciences sales and marketing function lacks a differentiated and coherent strategy to actively engage with its variety of stakeholders (physicians, patients, payers, pharmacists, nurse practitioners, and NGOs / advocacy groups). These firms struggle to…
  • State of the Market
    April 28, 2017

    This report provides an overview of the IT market for the healthcare payer industry. As the HLS market is expected to witness a slight course correction owing to several uncertainties, we have revised our projections for…
  • Thematic Report
    April 21, 2017

    The healthcare payer market is currently undergoing through a state of turbulence owing to regulatory uncertainty, fast-changing consumer dynamics, and tight competition. They are struggling to balance the dual mandate of cost containment and growth. Additionally,…
  • Blog
    April 19, 2017

    Did you know that global funding for startups dipped more than 20 percent in 2015-16? But that life sciences startups were a rare breed that continued to find favor with those who hold the purse strings?…

Items per page